SRE Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Sempra (SRE) is not a strong buy for a beginner, long-term investor at this time. The company's recent financial performance is weak, with declining revenue, net income, and EPS. Additionally, hedge funds are selling, and there is a legal investigation into potential securities fraud. While analysts maintain positive ratings and price targets, the lack of immediate positive catalysts and weak technical indicators suggest holding off on investment until clearer growth signals emerge.
The MACD is negatively expanding (-0.384), indicating bearish momentum. RSI is neutral at 37.043, and moving averages are converging, showing no clear trend. The stock is trading near support at 95.352, with resistance at 97.79. Overall, technical indicators do not suggest a strong buy signal.
Analysts have raised price targets consistently, with most maintaining Overweight or Buy ratings. Regulatory clarity and potential midyear updates are expected to provide positive catalysts.
Hedge funds are selling heavily, and there is a legal investigation into potential securities fraud. Recent financial performance has been weak, with significant declines in revenue, net income, and EPS. Technical indicators are bearish or neutral, and there is no immediate AI or SwingMax trading signal.
In Q4 2025, revenue dropped 0.24% YoY to $3.749 billion. Net income fell 47.07% YoY to $352 million, and EPS declined 48.08% YoY to 0.54. Gross margin also decreased by 3.86% YoY to 68.79%. Overall, financial performance shows significant weakness.
Analysts are broadly positive, with multiple firms raising price targets (e.g., Barclays to $105, Wells Fargo to $115, Morgan Stanley to $105). Most maintain Overweight or Buy ratings, citing regulatory clarity, growth opportunities, and catalysts for midyear updates.
